Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of F-18 FDG and C-11 Acetate PET/CT and PET/MRI in Multiple Myeloma
NCT03262389Phase 2Completed
- Start
- Sep 2017
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial. Primary endpoint: Mean Multiple Myeloma Lesions Detected at Day 2. Started Sep 2017; status: completed.
Beyond the preview
Go deeper on NCT03262389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03262389.